Fox News senior correspondent Jonathan Serrie reports on doctors seeing results from Daraxonrasib, a new drug targeting pancreatic cancer, on ‘Special Report.’ A new vaccine for the prevention of pancreatic cancer has shown promise in an early study at Johns Hopkins School of Medicine in Baltimore, Maryland. A phase 1 trial published in Cancer Discovery, a journal of the American Association for Cancer Research, tested an experimental vaccine called mKRAS-VAX in 20 people, according to a press release. Participants had an inherited risk of pancreatic ductal adenocarcinoma (PDAC), the most common and aggressive form of pancreatic cancer, along with an abnormality detected in imaging, typically a pancreatic cyst. These individuals had not been diagnosed with pancreatic cancer. NEW PANCREATIC CANCER PILL NEARLY DOUBLES SURVIVAL TIME IN BREAKTHROUGH TRIA
Jul 22, 2026 → Jul 22, 2026
Fox News senior correspondent Jonathan Serrie reports on doctors seeing results from Daraxonrasib, a new drug targeting pancreatic cancer, on ‘Special Report.’ A new vaccine for the prevention of pancreatic cancer has shown promise in an…
Read original at Fox News →1 updates from 1 source.
Fox News senior correspondent Jonathan Serrie reports on doctors seeing results from Daraxonrasib, a new drug targeting pancreatic cancer, on ‘Special Report.’ A new vaccine for the prevention of pancreatic cancer has…
Read original at Fox News →What this story stands on. Tier 0 is a primary record or the subject's own words; higher tiers must be attributed, never stated as bare fact.
Fox News senior correspondent Jonathan Serrie reports on doctors seeing results from Daraxonrasib, a new drug targeting pancreatic cancer, on ‘Special Report.’ A
View source →Tier key: T0 = Primary source · T1 = Wire · T2 = Outlet report · T3 = Commentary
Heidi Overton faced questions focused on vaccines, birth control, and vapes.
The three-star recruit from Baltimore had to wait until the end for his offer, but the Beavers are reaping immediate benefits as the freshman WR trails only Jeremiah Smith in…
Baltimore is reportedly sending Philadelphia a 2027 fifth-round pick and a 2028 second-rounder for Jurgens and a 2027 seventh-round pick
Lamar's injury lowers the ceiling for Baltimore's breakout star with Huntley under center, plus key Week 5 stats for Metcalf, London and Coleman
Newly obtained records indicate health secretary lied about Samoa trip during Senate confirmation hearings last year A senior Democratic senator is calling for a criminal…
The U.S. FDA has approved Revolution Medicinesâ groundbreaking pancreatic cancer drug after it was shown to double the survival rate of patients with advanced disease in a large…
